Инфузионная поддержка гентерапевтических технологий в лечении больных с синдромом диабетической стопы
Корейба Константин Александрович, Клюшкин Иван Владимирович Клюшкин, Руслан Ильгизарович Фатыхов et al. · The Bulletin of Contemporary Clinical Medicine · 2014
Syndrome of diabetic foot is one of terrible late complications of diabetes. Aim: to estimate influence of infusion therapy in combination with introduction of single cassette high purity supercoiled form of pCMV-VEGF165 plasmids on angiogenesis dynamics and the course of wound process in patients with neuroischemic diabetic foot with level of defeat of W 3-4 and a diabetic angiopathy with chronic arterial insufficiency IIIB-IVA. To develop modern high-technology approaches of therapy of patients with diabetic foot, allowing to reduce rate of high (superpatellar) amputations of lower extremities and to improve quality of life. Materials and methods. There were observed 5 patients with: a syndrome of diabetic foot, W 3-4 level of defeat, a diabetic angiopathy, chronic arterial insufficiency IIIB-IVA in stage of a neuroischemic form. Patients received single cassette high purity supercoiled form of pCMV-VEGF165 plasmids against infusion therapy. Results and discussion. We almost proved feasibility and efficiency of infusion support in case of application the single cassette high purity supercoiled form of pCMV-VEGF165 plasmids. Conclusion. Efficiency of infusion therapy with introduction the single cassette high purity supercoiled form of pCMV-VEGF165 plasmids is proved and is established effectively in case of treatment of patients with a syndrome of diabetic foot (classification by Wagner 3-4).
Cited by 0 works.